AstraZeneca to Buy TeneoTwo for Up to $1.27 Billion
05 Julho 2022 - 3:46AM
Dow Jones News
By Ian Walker
AstraZeneca PLC said Tuesday that it is buying TeneoTwo, Inc.
for up to $1.27 billion in a deal that strengthens its
haematological cancer pipeline.
The pharmaceutical giant said it will make an upfront payment of
$100 million upon closing of the deal. A further payment of up to
$805 million will be made dependent upon research-and-development
milestones being reached and extra payments of up to $360 million
could be payable to TeneoTwo shareholders based upon
commercial-related milestones.
Astra said the acquisition is expected to close in the third
quarter of this year and that it doesn't impact financial guidance
for the year.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
July 05, 2022 02:31 ET (06:31 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
